Purinergic Signalling

Papers
(The median citation count of Purinergic Signalling is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Some reflections after a long life in science45
Hippocampal astrocytes relieve anxiogenic behavior by increasing, via the release of ATP, excitatory synaptic transmission in dentate gyrus granule cells36
Substrate binding modes of purine and pyrimidine nucleotides to human ecto-5′-nucleotidase (CD73) and inhibition by their bisphosphonic acid derivatives31
Electroacupuncture may alleviate diabetic neuropathic pain by inhibiting the microglia P2X4R and neuroinflammation30
Role of the P2X7 receptor in breast cancer progression29
Purinergic P2X7 receptor involves in anti-retinal photodamage effects of berberine26
P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells22
Neuroprotection of exercise: P2X4R and P2X7R regulate BDNF actions22
Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas20
Moxibustion pre-treatment attenuates seizure severity during status epilepticus and counteracts the proconvulsant function of the purinergic P2X7 receptor19
The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine19
Promoting glymphatic flow: A non-invasive strategy using 40 Hz light flickering19
UTP is a regulator of in vitro and in vivo angiogenic properties of cardiac adipose–derived stem cells18
Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73)17
The exploration of active components of 701 Dieda Zhentong patch and analgesic properties on chronic constriction injury rats17
P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways17
Correction to: A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes15
Diadenosine pentaphosphate regulates dendrite growth and number in cultured hippocampal neurons15
Electroacupuncture may alleviate inflammatory pain by downregulating the expression of P2Y14 receptor in the primary somatosensory cortex15
ENTPD1 (CD39) and NT5E (CD73) expression in human medulloblastoma: an in silico analysis14
Effects of nanoflubendazole and purinergic signaling modulation in overcoming neuroblastoma chemoresistance14
Astrocytic adenosine A2B receptors: a crucial player in brain function14
Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation14
Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis13
Macrophage P2Y6 receptor signalling as a key mediator and therapeutic target in atherosclerosis13
Editorial: purinergic signalling—perspectives from Australia and New Zealand13
Purines help determine the gut’s sweet tooth12
Second meeting of the Australian and New Zealand Purine Club12
Purinergic P2X3 receptors in the carotid body as new therapeutic targets for controlling heart failure12
The P2Y2 receptor as a sensor of nucleotides and cell recruitment during inflammatory processes of the liver12
Inhibiting the P2Y13 receptor reduces IL-33 and HMGB1 lung concentrations and inflammatory cell infiltration in a murine model of asthma12
MicroRNA: Crucial modulator in purinergic signalling involved diseases11
Preface to special issue “A tribute to Maria Teresa Miras-Portugal”11
Pharmacological characterization of P2Y receptor subtypes – an update11
Pleiotropic effects of clopidogrel11
NPP1 and TNAP hydrolyze ATP synergistically during biomineralization11
Mono-ADP-ribosylation sites of human CD73 inhibit its adenosine-generating enzymatic activity11
May be adenosine an immuno-quorum-sensing signal?11
Purinergic ATP triggers moxibustion-induced local anti-nociceptive effect on inflammatory pain model11
Purinergic system in cancer stem cells10
Synthesis of new non-natural l-glycosidic flavonoid derivatives and their evaluation as inhibitors of Trypanosoma cruzi ecto-nucleoside triphosphate diphosphohydrolase 1 (TcNTPDase1)10
P2 purinergic receptor dysregulation in urologic disease10
Genetic polymorphisms of purinergic P2Y2 receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women10
Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonists10
RETRACTED ARTICLE: Lysophosphatidylcholine induces adenosine release from macrophages via TRPM7-mediated mitochondrial activation9
The anti-inflammatory effect of physical exercise on type 2 diabetes: the role of purinergic signaling9
P2Y6 promoted pruning of FSTL1 nerves by cutaneous macrophages to reset pain threshold and cardiac function9
Cutaneous melanoma and purinergic modulation by phenolic compounds9
P2Y11/IL-1 receptor crosstalk controls macrophage inflammation: a novel target for anti-inflammatory strategies?9
DUSP1/MKP-1 represents another piece in the P2X7R intracellular signaling puzzle in cerebellar cells: our last journey with Mª Teresa along the purinergic pathways of Eden8
Anti-inflammatory and analgesic properties of Polyphyllin VI revealed by network pharmacology and RNA sequencing8
The role of Pannexin-1 channels and extracellular ATP in the pathogenesis of the human immunodeficiency virus8
Mechanisms of ATP release in pain: role of pannexin and connexin channels8
Ginsenosides enhance P2X7-dependent cytokine secretion from LPS-primed rodent macrophages8
Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair8
Adenosine receptor signalling in Alzheimer’s disease8
Heterologous expression and biochemical characterization of the recombinant nucleoside triphosphate diphosphohydrolase 2 (LbNTPDase2) from Leishmania (Viannia) braziliensis7
P2Y11 receptor is a critical regulator of extracellular ATP-mediated premature senescence in lung fibroblasts: Implications of ER-Ca+2 release/mitochondrial ROS production signaling pathway7
Identification of novel proteins involved in P2X7-mediated signaling cascades7
Potential role of the P2X7 receptor in the proliferation of human diffused large B-cell lymphoma7
Fluorescent A2A and A3 adenosine receptor antagonists as flow cytometry probes7
Partners in health and disease: pineal gland and purinergic signalling7
Editorial—Translation of purinergic drugs into therapeutic use7
Correction to: The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia7
Analgesic effect of electroacupuncture on bone cancer pain in rat model: the role of peripheral P2X3 receptor6
Antagonism of the ATP-gated P2X7 receptor inhibits the proliferation of hepatocellular carcinoma cells6
Retraction Note: Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells6
Quinacrine is not a vital fluorescent probe for vesicular ATP storage6
Purinergic P2Y1 and P2Y12 receptors control enteric nervous system activity through neuro-glia-macrophage crosstalk6
Role and recent progress of P2Y12 receptor in cancer development6
T cell-derived adenosine regulates fibroblast IL-6 formation via A2B receptors in the infarcted heart6
P2 purinergic receptor expression and function in tumor-related immune cells6
CD39 in the development and progression of pulmonary arterial hypertension5
Molecular mechanisms of extracellular-ATP-mediated colorectal cancer progression: Implication of purinergic receptors-mediated nucleocytoplasmic shuttling of HuR5
EU COST Action CA21130 PRESTO ‘P2X receptors as therapeutic targets’ inaugural meeting report5
The enzymatic degradation of ATP to adenosine by microglial CD39 regulates neurovascular coupling and metabolic supply to the brain5
Correction to: Purinoceptor: a novel target for hypertension5
Purinergic signaling in liver disease: calcium signaling and induction of inflammation5
Announcement of changes to the Editorial Board5
Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review5
In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugs5
Gallic acid modulates purine metabolism and oxidative stress induced by ethanol exposure in zebrafish brain5
Mechanosensitive release of ATP in the urinary bladder mucosa5
The P2Y2 receptor: a new player in taste buds5
Ectonucleotidases as bridge between the ATP and adenosine world: reflections on Geoffrey Burnstock5
P2X receptors in the balance between inflammation and pathogen control in sepsis4
CD39 activities in the treated acupoints contributed to the analgesic mechanism of acupuncture on arthritis rats4
Burnstock oration — purinergic signalling in kidney transplantation4
Purinoceptor: a novel target for hypertension4
ATP released from dying cancer cells stimulates P2X4 receptors and mTOR in their neighbors4
Unexpected role of microglia and P2Y12 in the induction of and emergence from anesthesia4
Purinergic modulation of the immune response to infections4
Screening herbal and natural product libraries to aid discovery of novel allosteric modulators of human P2X74
Transactivation of receptor tyrosine kinases by purinergic P2Y and adenosine receptors4
The antidepressant-like effect of guanosine involves the modulation of adenosine A1 and A2A receptors4
Therapeutic potential of P2X7 receptor in retinal diseases4
Purinergic signaling: a potential therapeutic target for depression and chronic pain4
Adenosine signaling mediate pain transmission in the central nervous system4
Combined oral contraceptives alter ectonucleotidase and adenosine deaminase activities in peripheral blood cells4
Gene expression alterations of purinergic signaling components in obesity-associated intestinal low-grade inflammation in type 2 diabetes4
A major role for adenosine A2A receptor in the interaction between astrocytes and myelinated neurons: possible implications for the therapy of neurodegenerative disorders3
Caffeine plus haloperidol reduces fatigue in an experimental model of Parkinson's disease – a prospective to A2AR-D2R heterodimer antagonism3
P2Y14 receptors: a new target for treating ulcerative colitis3
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer—that is the question3
The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia3
The impact of purine nucleosides on neuroplasticity in the adult brain3
NT5E gene and CD38 protein as potential prognostic biomarkers for childhood B-acute lymphoblastic leukemia3
Spinal cord astrocyte P2X7Rs mediate the inhibitory effect of electroacupuncture on visceral hypersensitivity of rat with irritable bowel syndrome3
P2X7 receptor in macrophage polarization and its implications in neuroblastoma tumor behavior3
Is the regulation by miRNAs of NTPDase1 and ecto-5’-nucleotidase genes involved with the different profiles of breast cancer subtypes?3
The role of purinergic signaling in acupuncture-mediated relief of neuropathic and inflammatory pain3
Third meeting of the Australian and New Zealand Purine Club3
Schwann cells transplantation improves nerve injury and alleviates neuropathic pain in rats3
The P2X1 receptor as a therapeutic target3
Activation of P2X4 receptors in midbrain cerebrospinal fluid-contacting nucleus leads to mechanical hyperalgesia in chronic constriction injury rats3
Caffeine reduces viability, induces apoptosis, inhibits migration and modulates the CD39/CD73 axis in metastatic cutaneous melanoma cells3
Transcriptomic analysis reveals novel age-independent immunomodulatory proteins as a mode of cerebroprotection in P2X4 receptor knockout mice after ischemic stroke3
P2X7 receptor is essential for ST36-attenuated cardiac fibrosis upon beta-adrenergic insult2
Long non-coding RNA MSTRG.81401 short hairpin RNA relieves diabetic neuropathic pain and behaviors of depression by inhibiting P2X4 receptor expression in type 2 diabetic rats2
A step-by-step protocol based on data mining to explore purinergic signaling in glioblastoma2
Differently expression of the metabotropic P2Y receptor family after hypoxia-induced seizures in neonates and seizure suppression via P2Y1 receptor agonism2
P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells2
ADP as a novel stimulus for NLRP3-inflammasome activation in mice fails to translate to humans2
ATP breakdown in plasma of children limits the antimicrobial effectiveness of their neutrophils2
Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets2
Covalently Binding Adenosine A3 Receptor Agonist ICBM Irreversibly Reduces Voltage-Gated Ca2+ Currents in Dorsal Root Ganglion Neurons2
Involvement of purinergic signalling in the vasomotor response to hypochlorous acid in porcine coronary artery2
Caffeine: a potential mechanism for anti-obesity2
Role of the extracellular ATP/pyrophosphate metabolism cycle in vascular calcification2
Hematopoietic stem cells on the crossroad between purinergic signaling and innate immunity2
P2 X 7 receptor is a critical regulator of extracellular ATP-induced profibrotic genes expression in rat kidney: implication of transforming growth factor-β/Smad signaling pathway2
Publisher Correction to: Adenosine receptor signalling in Alzheimer’s disease2
P2 purinergic receptors regulate the progression of colorectal cancer2
Correction to: Regulation of TrkB receptor translocation to lipid rafts by adenosine A2A receptors and its functional implications for BDNF-induced regulation of synaptic plasticity2
Astrocytic P2X7 receptor regulates depressive-like behavioral reactions of mice in response to acute stressful stimulation2
Adenosine A2A receptor controls the gateway of the choroid plexus2
Functional role of P2X7 purinergic receptor in cancer and cancer-related pain2
Rosmarinic acid modulates purinergic signaling and induces apoptosis in melanoma cells2
P2X7 and P2Y1 receptors in DRG mediate electroacupuncture to inhibit peripheral sensitization in rats with IBS visceral pain2
P2Y12 receptor-mediated cyclooxygenase 2 (COX-2) expression enhances tumor cell progression in a mouse model of lymphoma2
Cell cycle regulation by ADP and IGF-1 in cultured late developing glia progenitors of the avian retina2
The P2X7 receptor is a target of p53 and regulates haematopoiesis following radiation-induced genotoxic stress2
SCH58261 effectively prevents the reduction in excitability of striatal MSNs in mice following 20 h of sleep deprivation2
P2X7 receptor: the regulator of glioma tumor development and survival2
ATP transporters in the joints1
Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral pain1
The real-time detection of acupuncture-induced extracellular ATP mobilization in acupoints and exploration of its role in acupuncture analgesia1
Electroacupuncture regulates the P2X7R-NLRP3 inflammatory cascade to relieve decreased sensation on ocular surface of type 2 diabetic rats with dry eye1
P2Y12 receptor gene polymorphisms are associated with epilepsy1
A2A receptors: a new target for immunotherapy resistance in prostate cancer1
The P2X7R is a crucial target for Angiotensin II-induced myocardial ferroptosis and remodeling1
Effect of chronic maternal L-Glu intake during gestation and/or lactation on oxidative stress markers, AMPA Glu1 receptor and adenosine A1 signalling pathway from foetal and neonatal cerebellum1
The developmental journey of therapies targeting purine receptors: from basic science to clinical trials1
Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease1
Istradefylline modulates purinergic enzymes and reduces malignancy-associated factors in B16F10 melanoma cells1
P2Y6R together with CYSLTR2 serves as endogenous receptor for long-chain ceramides in atherosclerosis1
Spinal P2X4 Receptors Involved in Visceral Hypersensitivity of Neonatal Maternal Separation Rats1
The striatum drives the ergogenic effects of caffeine1
Chemical biology-based approaches to study adenosine A2A − dopamine D2 receptor heteromers1
Correction to: P2 purinergic receptors regulate the progression of colorectal cancer1
Novel possibility for cutaneous melanoma treatment by means of rosmarinic acid action on purinergic signaling1
Species dependence of A3 adenosine receptor pharmacology and function1
Acute effects of guanosine or inosine in a porcine model of hemorrhagic shock1
Preclinical and clinical aspects of P2X receptors as a common route in different diseases: A meeting report1
Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists1
ATP, an attractive target for the treatment of refractory chronic cough1
Modulation of osteoblast differentiation and function by the P2X4 receptor1
Purinergic signaling in the peripheral vestibular system1
Purines and purinergic receptors in primary tumors of the central nervous system1
Machine learning-aided search for ligands of P2Y6 and other P2Y receptors1
Functional role of adenosine via KATP channels in cerebral capillary endothelial cells and pericytes1
Expanding the P2X7R toolbox: discovery of a novel Iodine-125 radioligand1
Blockage of the adenosine A2B receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension1
Molecular insights into P2X signalling cascades in acute kidney injury1
P2X7 receptors and pannexin1 hemichannels shape presynaptic transmission1
Enlightening activation gating in P2X receptors1
A new approach to psoriasis therapy: photoswitchable A3 adenosine receptor activation1
ATP release mediated by pannexin-3 is required for plasma cell survival via P2X4 receptors in bone marrow1
P2X7Rs: new therapeutic targets for osteoporosis1
The circadian regulation of extracellular ATP1
Retraction Note: Lysophosphatidylcholine induces adenosine release from macrophages via TRPM7-mediated mitochondrial activation1
CD73 polymorphisms are associated with schizophrenia1
Reprogramming the tumor microenvironment by targeting cytidine deaminase in pancreatic ductal adenocarcinoma tumors: implications for the role of P2Y6 receptors1
Functional expression of the ATP-gated P2X7 receptor in human iPSC-derived astrocytes1
Microglial purinergic signaling in Alzheimer’s disease1
First evidence of Tityus confluens Borelli, 1899 (Buthidae) venom altering purine metabolism in rat blood cells1
P2X3 receptors in the paraventricular hypothalamus: a specific target for visceral pain1
ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis1
A2B adenosine receptor signaling and regulation1
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons1
P2X7-mediated alteration of membrane fluidity is associated with the late stages of age-related macular degeneration1
Role of ecto-5’-nucleotidase in bladder function activity and smooth muscle contractility1
Regulation of transcription factor function by purinergic signalling in cardiovascular diseases1
Pharmacological differences between human and mouse P2X4 receptor explored using old and new tools1
Novel synthesized ionizable lipid for LNP-mediated P2X7siRNA to inhibit migration and induce apoptosis of breast cancer cells1
How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors1
Purinergic signaling in health: special issue of purines 2022 in Brazil1
Editorial: Small molecules and biologics for future purinergic therapeutics1
0.045622825622559